Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 147

1.

High Quality Light Field Extraction and Post-Processing for Raw Plenoptic Data.

Matysiak P, Grogan M, Le Pendu M, Alain M, Zerman E, Smolic A.

IEEE Trans Image Process. 2020 Jan 23. doi: 10.1109/TIP.2020.2967600. [Epub ahead of print]

PMID:
31995492
2.

Amyloidosis in surgically resected atrial appendages: a study of 345 consecutive cases with clinical implications.

Fayyaz AU, Bois MC, Dasari S, Padmanabhan D, Vrana JA, Stulak JM, Edwards WD, Kurtin PJ, Asirvatham SJ, Grogan M, Maleszewski JJ.

Mod Pathol. 2019 Nov 13. doi: 10.1038/s41379-019-0407-5. [Epub ahead of print]

PMID:
31723241
3.

Transthyretin amyloidosis: Putting myopathy on the map.

Pinto MV, Milone M, Mauermann ML, Dyck PJB, Alhammad R, McPhail ED, Grogan M, Liewluck T.

Muscle Nerve. 2020 Jan;61(1):95-100. doi: 10.1002/mus.26723. Epub 2019 Oct 21.

PMID:
31587306
4.

Expert Consensus Recommendations for the Suspicion and Diagnosis of Transthyretin Cardiac Amyloidosis.

Maurer MS, Bokhari S, Damy T, Dorbala S, Drachman BM, Fontana M, Grogan M, Kristen AV, Lousada I, Nativi-Nicolau J, Cristina Quarta C, Rapezzi C, Ruberg FL, Witteles R, Merlini G.

Circ Heart Fail. 2019 Sep;12(9):e006075. doi: 10.1161/CIRCHEARTFAILURE.119.006075. Epub 2019 Sep 4.

PMID:
31480867
5.

Advances in the treatment of hereditary transthyretin amyloidosis: A review.

Gertz MA, Mauermann ML, Grogan M, Coelho T.

Brain Behav. 2019 Sep;9(9):e01371. doi: 10.1002/brb3.1371. Epub 2019 Aug 1. Review.

6.

Depth of organ response in AL amyloidosis is associated with improved survival: new proposed organ response criteria.

Muchtar E, Dispenzieri A, Leung N, Lacy MQ, Buadi FK, Dingli D, Grogan M, Hayman SR, Kapoor P, Hwa YL, Fonder A, Hobbs M, Chakraborty R, Gonsalves W, Kourelis TV, Warsame R, Russell S, Lust JA, Lin Y, Go RS, Zeldenrust S, Kyle RA, Rajkumar SV, Kumar SK, Gertz MA.

Amyloid. 2019;26(sup1):101-102. doi: 10.1080/13506129.2019.1582486. No abstract available.

PMID:
31343331
7.

Transthyretin amyloidosis in patients with undifferentiated heart failure.

Chang IC, Scott CG, Dispenzieri A, AbouEzzeddine O, Lin G, Grogan M.

Amyloid. 2019;26(sup1):33-34. doi: 10.1080/13506129.2019.1582502. No abstract available.

PMID:
31343280
8.

Analysis of the Stomal Microbiota of a Percutaneous Osseointegrated Prosthesis: A Longitudinal Prospective Cohort Study.

Beck JP, Grogan M, Bennett BT, Jeyapalina S, Agarwal J, Bartow-McKenney C, Bugayev J, Kubiak E, Sinclair S, Grice E.

J Orthop Res. 2019 Dec;37(12):2645-2654. doi: 10.1002/jor.24421. Epub 2019 Aug 2.

PMID:
31317568
9.

Ten-year survivors in AL amyloidosis: characteristics and treatment pattern.

Muchtar E, Gertz MA, Lacy MQ, Go RS, Buadi FK, Dingli D, Grogan M, AbouEzzeddine OF, Hayman SR, Kapoor P, Leung N, Fonder A, Hobbs M, Hwa YL, Gonsalves W, Warsame R, Kourelis TV, Russell S, Lust JA, Lin Y, Zeldenrust S, Kyle RA, Rajkumar SV, Kumar SK, Dispenzieri A.

Br J Haematol. 2019 Dec;187(5):588-594. doi: 10.1111/bjh.16096. Epub 2019 Jul 12.

PMID:
31298751
10.

Myocardial Stiffness by Intrinsic Cardiac Elastography in Patients with Amyloidosis: Comparison with Chamber Stiffness and Global Longitudinal Strain.

Pislaru C, Ionescu F, Alashry M, Petrescu I, Pellikka PA, Grogan M, Dispenzieri A, Pislaru SV.

J Am Soc Echocardiogr. 2019 Aug;32(8):958-968.e4. doi: 10.1016/j.echo.2019.04.418. Epub 2019 Jun 21.

PMID:
31230779
11.

Reply: Cardiac Amyloidosis, Atrial Arrhythmias, Thrombus, and Stroke: A Vexing Problem.

El-Am EA, Dispenzieri A, Grogan M, Nkomo VT.

J Am Coll Cardiol. 2019 Jun 11;73(22):2911-2913. doi: 10.1016/j.jacc.2019.04.005. No abstract available.

PMID:
31171105
12.

Transthyretin Amyloid Cardiomyopathy: JACC State-of-the-Art Review.

Ruberg FL, Grogan M, Hanna M, Kelly JW, Maurer MS.

J Am Coll Cardiol. 2019 Jun 11;73(22):2872-2891. doi: 10.1016/j.jacc.2019.04.003. Review.

PMID:
31171094
13.

Research Techniques Made Simple: Profiling the Skin Microbiota.

Grogan MD, Bartow-McKenney C, Flowers L, Knight SAB, Uberoi A, Grice EA.

J Invest Dermatol. 2019 Apr;139(4):747-752.e1. doi: 10.1016/j.jid.2019.01.024.

PMID:
30904077
14.

Teaching NeuroImages: Neuromyopathy in a patient with hereditary transthyretin Thr60Ala amyloidosis.

Pinto MV, Tracy JA, Grogan M, Mauermann ML.

Neurology. 2019 Mar 19;92(12):e1403-e1404. doi: 10.1212/WNL.0000000000007143. No abstract available.

PMID:
30886082
15.

Transthyretin Stabilization by AG10 in Symptomatic Transthyretin Amyloid Cardiomyopathy.

Judge DP, Heitner SB, Falk RH, Maurer MS, Shah SJ, Witteles RM, Grogan M, Selby VN, Jacoby D, Hanna M, Nativi-Nicolau J, Patel J, Rao S, Sinha U, Turtle CW, Fox JC.

J Am Coll Cardiol. 2019 Jul 23;74(3):285-295. doi: 10.1016/j.jacc.2019.03.012. Epub 2019 Mar 15.

16.

Two types of amyloidosis presenting in a single patient: a case series.

Sidiqi MH, McPhail ED, Theis JD, Dasari S, Vrana JA, Drosou ME, Leung N, Hayman S, Rajkumar SV, Warsame R, Ansell SM, Gertz MA, Grogan M, Dispenzieri A.

Blood Cancer J. 2019 Mar 5;9(3):30. doi: 10.1038/s41408-019-0193-9.

17.

Monoclonal gammopathy plus positive amyloid biopsy does not always equal AL amyloidosis.

Sidiqi MH, Dasari S, McPhail ED, Buadi FK, Warsame R, Lacy MQ, Dingli D, Gonsalves WI, Kapoor P, Kourelis T, Leung N, Muchtar E, Grogan M, Lust JA, Kumar S, Kyle RA, Rajkumar VS, Gertz M, Dispenzieri A.

Am J Hematol. 2019 May;94(5):E141-E143. doi: 10.1002/ajh.25440. Epub 2019 Feb 27. No abstract available.

PMID:
30773682
18.

Direct Current Cardioversion of Atrial Arrhythmias in Adults With Cardiac Amyloidosis.

El-Am EA, Dispenzieri A, Melduni RM, Ammash NM, White RD, Hodge DO, Noseworthy PA, Lin G, Pislaru SV, Egbe AC, Grogan M, Nkomo VT.

J Am Coll Cardiol. 2019 Feb 12;73(5):589-597. doi: 10.1016/j.jacc.2018.10.079.

19.

Prognostic Significance of Holter Monitor Findings in Patients With Light Chain Amyloidosis.

Sidana S, Tandon N, Brady PA, Grogan M, Gertz MA, Dispenzieri A, Lin G, Dingli D, Buadi FK, Lacy MQ, Kapoor P, Gonsalves WI, Muchtar E, Warsame R, Kumar SK, Kourelis TV.

Mayo Clin Proc. 2019 Mar;94(3):455-464. doi: 10.1016/j.mayocp.2018.08.039. Epub 2019 Feb 2.

PMID:
30718070
20.

Utility of the Serum Free Light Chain Assay in the Diagnosis of Light Chain Amyloidosis in Patients With Heart Failure.

Chang IC, Dispenzieri A, Scott CG, Lin G, Jaffe AS, Klarich KW, Grogan M.

Mayo Clin Proc. 2019 Mar;94(3):447-454. doi: 10.1016/j.mayocp.2018.07.025. Epub 2019 Feb 2.

PMID:
30718069
21.

Contemporary Imaging Diagnosis of Cardiac Amyloidosis.

Lee SP, Park JB, Kim HK, Kim YJ, Grogan M, Sohn DW.

J Cardiovasc Imaging. 2019 Jan;27(1):1-10. doi: 10.4250/jcvi.2019.27.e9. Review.

22.

Effects of Patisiran, an RNA Interference Therapeutic, on Cardiac Parameters in Patients With Hereditary Transthyretin-Mediated Amyloidosis.

Solomon SD, Adams D, Kristen A, Grogan M, González-Duarte A, Maurer MS, Merlini G, Damy T, Slama MS, Brannagan TH 3rd, Dispenzieri A, Berk JL, Shah AM, Garg P, Vaishnaw A, Karsten V, Chen J, Gollob J, Vest J, Suhr O.

Circulation. 2019 Jan 22;139(4):431-443. doi: 10.1161/CIRCULATIONAHA.118.035831.

PMID:
30586695
23.

Staging systems use for risk stratification of systemic amyloidosis in the era of high-sensitivity troponin T assay.

Muchtar E, Kumar SK, Gertz MA, Grogan M, AbouEzzeddine OF, Jaffe AS, Dispenzieri A.

Blood. 2019 Feb 14;133(7):763-766. doi: 10.1182/blood-2018-10-875252. Epub 2018 Dec 13. No abstract available.

PMID:
30545829
24.

Increased Myocardial Stiffness Detected by Intrinsic Cardiac Elastography in Patients With Amyloidosis: Impact on Outcomes.

Pislaru C, Alashry MM, Ionescu F, Petrescu I, Pellikka PA, Grogan M, Dispenzieri A, Pislaru SV.

JACC Cardiovasc Imaging. 2019 Feb;12(2):375-377. doi: 10.1016/j.jcmg.2018.08.014. Epub 2018 Oct 17. No abstract available.

25.

Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy.

Maurer MS, Schwartz JH, Gundapaneni B, Elliott PM, Merlini G, Waddington-Cruz M, Kristen AV, Grogan M, Witteles R, Damy T, Drachman BM, Shah SJ, Hanna M, Judge DP, Barsdorf AI, Huber P, Patterson TA, Riley S, Schumacher J, Stewart M, Sultan MB, Rapezzi C; ATTR-ACT Study Investigators.

N Engl J Med. 2018 Sep 13;379(11):1007-1016. doi: 10.1056/NEJMoa1805689. Epub 2018 Aug 27.

26.

Cardiac amyloidosis in aortic stenosis-icebergs and Archimedes' principle.

Java AP, Greason KL, Dispenzieri A, Grogan M, Maleszewki JJ, Daly RC, Eleid MF, Schaff HV.

J Thorac Cardiovasc Surg. 2018 Sep;156(3):966-967. doi: 10.1016/j.jtcvs.2018.04.052. No abstract available.

PMID:
30119291
27.

LLY-283, a Potent and Selective Inhibitor of Arginine Methyltransferase 5, PRMT5, with Antitumor Activity.

Bonday ZQ, Cortez GS, Grogan MJ, Antonysamy S, Weichert K, Bocchinfuso WP, Li F, Kennedy S, Li B, Mader MM, Arrowsmith CH, Brown PJ, Eram MS, Szewczyk MM, Barsyte-Lovejoy D, Vedadi M, Guccione E, Campbell RM.

ACS Med Chem Lett. 2018 Apr 23;9(7):612-617. doi: 10.1021/acsmedchemlett.8b00014. eCollection 2018 Jul 12.

28.

Independent Prognostic Value of Stroke Volume Index in Patients With Immunoglobulin Light Chain Amyloidosis.

Milani P, Dispenzieri A, Scott CG, Gertz MA, Perlini S, Mussinelli R, Lacy MQ, Buadi FK, Kumar S, Maurer MS, Merlini G, Hayman SR, Leung N, Dingli D, Klarich KW, Lust JA, Lin Y, Kapoor P, Go RS, Pellikka PA, Hwa YL, Zeldenrust SR, Kyle RA, Rajkumar SV, Grogan M.

Circ Cardiovasc Imaging. 2018 May;11(5):e006588. doi: 10.1161/CIRCIMAGING.117.006588.

29.

MRI feature tracking strain is prognostic for all-cause mortality in AL amyloidosis.

Illman JE, Arunachalam SP, Arani A, Chang IC, Glockner JF, Dispenzieri A, Grogan M, Araoz PA.

Amyloid. 2018 Jun;25(2):101-108. doi: 10.1080/13506129.2018.1465406. Epub 2018 May 7.

30.

Outcomes After Cardiac Transplant for Wild Type Transthyretin Amyloidosis.

Rosenbaum AN, AbouEzzeddine OF, Grogan M, Dispenzieri A, Kushwaha S, Clavell A, Daly RC, Edwards BS.

Transplantation. 2018 Nov;102(11):1909-1913. doi: 10.1097/TP.0000000000002240.

PMID:
29677073
31.

Depth of organ response in AL amyloidosis is associated with improved survival: grading the organ response criteria.

Muchtar E, Dispenzieri A, Leung N, Lacy MQ, Buadi FK, Dingli D, Grogan M, Hayman SR, Kapoor P, Hwa YL, Fonder A, Hobbs M, Chakraborty R, Gonsalves W, Kourelis TV, Warsame R, Russell S, Lust JA, Lin Y, Go RS, Zeldenrust S, Kyle RA, Rajkumar SV, Kumar SK, Gertz MA.

Leukemia. 2018 Oct;32(10):2240-2249. doi: 10.1038/s41375-018-0060-x. Epub 2018 Feb 20.

PMID:
29581546
32.

Digoxin use in systemic light-chain (AL) amyloidosis: contra-indicated or cautious use?

Muchtar E, Gertz MA, Kumar SK, Lin G, Boilson B, Clavell A, Lacy MQ, Buadi FK, Hayman SR, Kapoor P, Dingli D, Rajkumar SV, Dispenzieri A, Grogan M.

Amyloid. 2018 Jun;25(2):86-92. doi: 10.1080/13506129.2018.1449744. Epub 2018 Mar 12.

PMID:
29529877
33.

Spectrum of Restrictive and Infiltrative Cardiomyopathies: Part 2 of a 2-Part Series.

Pereira NL, Grogan M, Dec GW.

J Am Coll Cardiol. 2018 Mar 13;71(10):1149-1166. doi: 10.1016/j.jacc.2018.01.017. Review.

34.

Spectrum of Restrictive and Infiltrative Cardiomyopathies: Part 1 of a 2-Part Series.

Pereira NL, Grogan M, Dec GW.

J Am Coll Cardiol. 2018 Mar 13;71(10):1130-1148. doi: 10.1016/j.jacc.2018.01.016. Review.

35.

Aortic valve replacement in patients with amyloidosis.

Java AP, Greason KL, Dispenzieri A, Grogan M, King KS, Maleszewski JJ, Daly RC, Eleid MF, Pochettino A, Schaff HV.

J Thorac Cardiovasc Surg. 2018 Jul;156(1):98-103. doi: 10.1016/j.jtcvs.2017.12.048. Epub 2017 Dec 19.

PMID:
29397971
36.

Hydroxychloroquine-Mediated Cardiotoxicity With a False-Positive 99mTechnetium-Labeled Pyrophosphate Scan for Transthyretin-Related Cardiac Amyloidosis.

Chang ICY, Bois JP, Bois MC, Maleszewski JJ, Johnson GB, Grogan M.

Circ Cardiovasc Imaging. 2018 Jan;11(1). pii: e007059. doi: 10.1161/CIRCIMAGING.117.007059. No abstract available.

PMID:
29288196
37.

Outcomes of Patients With Familial Transthyretin Amyloidosis After Liver Transplantation.

Banerjee D, Roeker LE, Grogan M, Swiecicki P, Poterucha J, Heimbach J, Zeldenrust S, Gertz M, Edwards B, Daly R, Klarich KW, Dispenzieri A.

Prog Transplant. 2017 Sep;27(3):246-250. doi: 10.1177/1526924817715463. Epub 2017 Jul 4.

PMID:
29187090
38.

Acquired transthyretin amyloidosis after domino liver transplant: Phenotypic correlation, implication of liver retransplantation.

Muchtar E, Grogan M, Dasari S, Kurtin PJ, Gertz MA.

J Neurol Sci. 2017 Aug 15;379:192-197. doi: 10.1016/j.jns.2017.06.013. Epub 2017 Jun 13.

PMID:
28716239
39.

Light-chain cardiac amyloidosis: strategies to promote early diagnosis and cardiac response.

Grogan M, Dispenzieri A, Gertz MA.

Heart. 2017 Jul;103(14):1065-1072. doi: 10.1136/heartjnl-2016-310704. Epub 2017 Apr 29. Review.

40.

Apolipoprotein A-IV-Associated Cardiac Amyloidosis.

Bois MC, Dasari S, Mills JR, Theis J, Highsmith WE, Vrana JA, Grogan M, Dispenzieri A, Kurtin PJ, Maleszewski JJ.

J Am Coll Cardiol. 2017 May 2;69(17):2248-2249. doi: 10.1016/j.jacc.2017.02.047. No abstract available.

41.

Recommendations from the Amyloidosis Research Consortium Educational Roundtable at the American College of Cardiology Annual Meeting, 1 April 2016.

Maurer M, Lousada I, Hanna M, Ruberg F, Mohty D, Dispenzieri A, Liedtke M, Paulson I, Vest J, Grogan M.

Amyloid. 2017 Mar;24(sup1):165-166. doi: 10.1080/13506129.2017.1286582. No abstract available.

PMID:
28434366
42.

Feasibility study of cardiac magnetic resonance elastography in cardiac amyloidosis.

Chang ICY, Arani A, Poigai Arunachalam S, Grogan M, Dispenzieri A, Araoz PA.

Amyloid. 2017 Mar;24(sup1):161. doi: 10.1080/13506129.2017.1278689. No abstract available.

43.

Complex p.T88N/W130R mutation in the lysozyme gene leading to hereditary lysozyme amyloidosis with biopsy-proven cardiac involvement.

Sperry BW, Dispenzieri A, Ikram A, Grogan M, Theis JD, Leung N, Highsmith WE, Maleszewski JJ, Hanna M.

Amyloid. 2017 Mar;24(1):60-61. doi: 10.1080/13506129.2016.1269738. Epub 2017 Mar 22. No abstract available.

PMID:
28330375
44.

Cardiac MR elastography for quantitative assessment of elevated myocardial stiffness in cardiac amyloidosis.

Arani A, Arunachalam SP, Chang ICY, Baffour F, Rossman PJ, Glaser KJ, Trzasko JD, McGee KP, Manduca A, Grogan M, Dispenzieri A, Ehman RL, Araoz PA.

J Magn Reson Imaging. 2017 Nov;46(5):1361-1367. doi: 10.1002/jmri.25678. Epub 2017 Feb 25.

45.

Cardiac Myxoma: The Great Mimicker.

El Sabbagh A, Al-Hijji MA, Thaden JJ, Pislaru SV, Pislaru C, Pellikka PA, Arruda-Olson AM, Grogan M, Greason KL, Maleszewski JJ, Klarich KW, Nkomo VT.

JACC Cardiovasc Imaging. 2017 Feb;10(2):203-206. doi: 10.1016/j.jcmg.2016.06.018. No abstract available.

46.

Improved outcomes for newly diagnosed AL amyloidosis between 2000 and 2014: cracking the glass ceiling of early death.

Muchtar E, Gertz MA, Kumar SK, Lacy MQ, Dingli D, Buadi FK, Grogan M, Hayman SR, Kapoor P, Leung N, Fonder A, Hobbs M, Hwa YL, Gonsalves W, Warsame R, Kourelis TV, Russell S, Lust JA, Lin Y, Go RS, Zeldenrust S, Kyle RA, Rajkumar SV, Dispenzieri A.

Blood. 2017 Apr 13;129(15):2111-2119. doi: 10.1182/blood-2016-11-751628. Epub 2017 Jan 26.

47.

Diagnosis and Management of Waldenström Macroglobulinemia: Mayo Stratification of Macroglobulinemia and Risk-Adapted Therapy (mSMART) Guidelines 2016.

Kapoor P, Ansell SM, Fonseca R, Chanan-Khan A, Kyle RA, Kumar SK, Mikhael JR, Witzig TE, Mauermann M, Dispenzieri A, Ailawadhi S, Stewart AK, Lacy MQ, Thompson CA, Buadi FK, Dingli D, Morice WG, Go RS, Jevremovic D, Sher T, King RL, Braggio E, Novak A, Roy V, Ketterling RP, Greipp PT, Grogan M, Micallef IN, Bergsagel PL, Colgan JP, Leung N, Gonsalves WI, Lin Y, Inwards DJ, Hayman SR, Nowakowski GS, Johnston PB, Russell SJ, Markovic SN, Zeldenrust SR, Hwa YL, Lust JA, Porrata LF, Habermann TM, Rajkumar SV, Gertz MA, Reeder CB.

JAMA Oncol. 2017 Sep 1;3(9):1257-1265. doi: 10.1001/jamaoncol.2016.5763. Review.

48.

Ventricular-Arterial Function and Coupling in the Adult Fontan Circulation.

Saiki H, Eidem BW, Ohtani T, Grogan MA, Redfield MM.

J Am Heart Assoc. 2016 Sep 23;5(9). pii: e003887.

49.

Prognosis of Light Chain Amyloidosis With Preserved LVEF: Added Value of 2D Speckle-Tracking Echocardiography to the Current Prognostic Staging System.

Barros-Gomes S, Williams B, Nhola LF, Grogan M, Maalouf JF, Dispenzieri A, Pellikka PA, Villarraga HR.

JACC Cardiovasc Imaging. 2017 Apr;10(4):398-407. doi: 10.1016/j.jcmg.2016.04.008. Epub 2016 Sep 14.

50.

Natural History of Wild-Type Transthyretin Cardiac Amyloidosis and Risk Stratification Using a Novel Staging System.

Grogan M, Scott CG, Kyle RA, Zeldenrust SR, Gertz MA, Lin G, Klarich KW, Miller WL, Maleszewski JJ, Dispenzieri A.

J Am Coll Cardiol. 2016 Sep 6;68(10):1014-20. doi: 10.1016/j.jacc.2016.06.033. Erratum in: J Am Coll Cardiol. 2017 Jun 13;69(23):2882.

Supplemental Content

Loading ...
Support Center